Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT AGREEMENTAmendment Agreement • March 4th, 2009 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2009 Company IndustryIDENIX PHARMACEUTICALS, INC., a corporation organized and existing under the laws of the State of Delaware, having its principal offices located at 60 Hampshire Street, Cambridge, MA 02139 represented by its legal representative Mr. Jean-Pierre Sommadossi (hereinafter referred to as “Idenix”);
Amendment No. 1 to Employment AgreementEmployment Agreement • March 4th, 2009 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2009 Company IndustryThis Amendment No. 1 to the Employment Agreement (as defined below) (the “Amendment”), is made this 23rd day of December, 2008 between Idenix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of Delaware (together with its successors and assigns, the “Company”) and Dr. Jean-Pierre Sommadossi, a resident of the Commonwealth of Massachusetts, and the Company’s Chairman, President and Chief Executive Officer (the “Employee”).
Confidential Materials omitted and separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE AGREEMENTLicense Agreement • March 4th, 2009 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 4th, 2009 Company Industry JurisdictionThis License Agreement (the “Agreement”) is entered into as of the 4th day of February 2009 (the “Execution Date”) by and between Idenix Pharmaceuticals, Inc., a company organized under the laws of the State of Delaware with its principal place of business at 60 Hampshire Street, Cambridge, Massachusetts 02139, USA (“Idenix”), and SmithKline Beecham Corporation, doing business as GlaxoSmithKline, a company organized under the laws of the Commonwealth of Pennsylvania, with its principal place of business at One Franklin Plaza, Philadelphia, Pennsylvania 19101 USA (“GSK”).
Confidential Materials omitted and field separately with the Securities and Exchange Commission. Asterisks denote omissions. AGREEMENTCollaboration Agreement • March 4th, 2009 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2009 Company IndustryIDENIX PHARMACEUTICALS, INC., a corporation organized and existing under the laws of the State of Delaware, having its principal offices located at 60 Hampshire Street, Cambridge, MA 02139 represented by its legal representative Mr. Jean-Pierre Sommadossi (hereinafter referred to as “Idenix”)